T RANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE)
is a widely used imaging technique for perioperative evaluation of cardiac function and intrathoracic vascular structures. 1 Imaging of the thoracic aorta is part of the standard intraoperative TEE examination as recommended by the Society of Cardiovascular Anesthesiologists. 2 Most of the thoracic aorta can routinely be imaged with multiplane TEE because it is adjacent to the esophagus as it passes vertically through the mediastinum. However, a major limitation of conventional TEE remains the so-called "blind spot." Because of the interposition of the air-filled trachea between the esophagus and the distal ascending aorta (AA) and proximal aortic arch, these regions usually cannot be visualized with conventional TEE. 3 The distal ascending aorta is the location for aortic clamping and cannulation. Manipulation of an often atherosclerotic aorta can dislodge atherosclerotic debris and cause a postoperative stroke. In a recent meta-analysis, based on all available quantitative evidence of the diagnostic accuracy of TEE for the detection of atherosclerosis in the AA, it was shown that conventional TEE is not capable of adequately assessing the AA for clinically relevant atherosclerosis. 4 The latter is most likely caused by the "blind spot" of TEE. In case of an aortic dissection, there is an increased risk of malperfusion of the cerebrum because of extension of the intimal dissection into the innominate or carotid artery.
The authors recently improved conventional TEE to overcome the "blind spot" of TEE. The method, further referred to as the "A-View (aortic view) method," uses a fluid-filled balloon catheter (A-View Catheter; Cordatec Inc, Zoersel, Belgium; Fig 1) in the trachea in combination with conventional TEE. In a previously published, diagnostic study evaluating this new method in 41 patients undergoing cardiac surgery, the distal AA was visible in all (100%) patients with the A-View method and only in 9.8% with conventional TEE. There were no clinically important side effects associated with the use of the A-View catheter. The severity of atherosclerosis visualized with the A-View method compared with epiaortic ultrasound results showed good agreement between the 2 methods (kappa of 0.69 [0.50-0.88]). 5 The aim of this article is to describe this new diagnostic method, its potential views, indications, and risks.
THE CLINICAL APPLICATION OF THE A-VIEW METHOD
The patients described in this article all gave written informed consent to use their clinical data. The A-View method is approved for clinical use by both Conformité Européene (CE) marking and the United States Food and Drug Administration and thus may be used for diagnostic purposes in patients.
The A-View method uses a saline-filled balloon catheter to replace the air in the tracheobronchial tree during the investigation (Fig 2) . This fluid creates an ultrasound-conducting window and the possibility of imaging the distal part of the ascending aorta by conventional TEE in the anesthetized patient during a short (2-3 minutes) period of apnea.
The A-View catheter is a saline-filled endotracheal balloon catheter consisting of an external filling catheter of 50 cm, a highly compliant airway balloon connected to a stiff 4F distal perforated line of 30 cm, and an external pressure balloon mounted on a side line. The airway balloon is oversized, with a length of 10 cm and width of 3 cm, in order to cover the left main bronchus and trachea without the
